<DOC>
	<DOCNO>NCT01434745</DOCNO>
	<brief_summary>The purpose study determine simvastatin improve development behavior patient Smith Lemli-Opitz syndrome ( SLOS ) receive dietary cholesterol supplementation .</brief_summary>
	<brief_title>SLOS : The Effect Simvastatin Patients Receiving Cholesterol Supplementation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Male female 1 year old Subject confirm diagnosis SmithLemliOpitz Syndrome Subject currently receive cholesterol supplementation Subjects ill travel study site Subjects unable safely undergo study procedure Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>SLOS</keyword>
	<keyword>Cholesterol Supplementation</keyword>
	<keyword>Simvastatin</keyword>
</DOC>